SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-22-008007
Filing Date
2022-07-27
Accepted
2022-07-27 16:24:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP gsk-sc13d_071722.htm SC 13D 118547
2 LOCK-UP AGREEMENT ex99-6.htm EX-99.6 337650
3 ORDERLY MARKETING AGREEMENT ex99-7.htm EX-99.7 213126
4 ORDERLY MARKETING AGREEMENT SIDE LETTER ex99-8.htm EX-99.8 161095
  Complete submission text file 0001387131-22-008007.txt   832160
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GSK PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address BUILDING 5, FIRST FLOOR THE HEIGHTS WEYBRIDGE X0 KT13 0NY
Business Address BUILDING 5, FIRST FLOOR THE HEIGHTS WEYBRIDGE X0 KT13 0NY 44 1932 822000
Haleon plc (Subject) CIK: 0001900304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93722 | Film No.: 221111313
SIC: 2844 Perfumes, Cosmetics & Other Toilet Preparations